Journal of Hematology and Oncology Research

The Open Access Pub has the reputation for quick reviewing and publishing original research articles. The editorial boards of our journals have many dedicated and reputed scientists as editorial members. Their support helps many researchers from all countries to enhance their research between scientists of various communities. This platform plays a crucial role in promoting science networks and exchanges.

Hematology and Oncology Research-Cancer biomarker research.
-Umit Tapan

United States

Boston University Medical Center

Send an Email

Umit Tapan


820 Harrison Avenue
FGH Building 1st Floor
Boston, MA, 02118
United States

Research Interests:

Cancer biomarker research.


  • My interest in clinical research started during my residency. 
  • While at a tertiary referral cancer center in Turkey I had the opportunity to contribute to several clinical research projects. 
  • One of these studies evaluated the frequency and determinants of metabolic syndrome in breast cancer patients. 
  • Our exciting results shed light into possible contribution of aromatase inhibitors to development of metabolic syndrome. 
  • Through another study on management of brain metastases from breast cancer, we were able to elucidate clinical prognostic factors for this dismal condition. 
  • I was fortunate to continue my journey in the field of clinical research in the United States during internal medicine residency and currently with a Hematology/Oncology fellowship at Boston University. 
  • During first year of my residency I designed and performed a retrospective study which revealed high B-natriuretic peptide levels in amyloidosis patients treated with lenalidomide. 
  • It was the first study reporting such association; the results were presented at ASH 2012 and was published in Blood Journal. 
  • I also had the opportunity to design, conduct and analyze a retrospective study looking into the association between heparin-platelet factor 4 antibody and mortality. 
  • The results were presented at ASH 2013 and is under review for publication in Platelet Journal. 
  • Currently, while in my fellowship, I am focusing on the predictive role of a biomarker for EGFR targeted therapy in metastatic colorectal cancer patients, which I think will have a major impact on how we treat colorectal cancer patients. 
  • The study is currently at the last stage with completion of pathological assessment of biomarkers and pending for analysis of the association between clinical responses and level of biomarker expression. 
  • The hands-on experience I had in the translational lab was invaluable and encouraged me to continue with further translational projects.
  • I am also working on a retrospective study in different cancer types, to look for the association between topo-I-pS10 levels and clinical response to topo-I inhibitors. 

Positions and Honors.   

  • 06/2005 - 05/2009       Internal Medicine Residency, Hacettepe Univ. Hospital, Ankara, Turkey
  • 06/2009 - 06/2012       Internal Medicine Residency, Steward Carney Hospital, Boston, MA
  • 07/2012 - Present        Hematology/Oncology Fellowship, Boston University Medical Center, Boston, MA


  • 12/1998 - Ranked 1st in the Eastern Region in the National Biology Exam (Turkey)
  • 06/2000- Ranked in top 1% in the National University Entrance Exam (Turkey)
  • 09/2006- Ranked in top 1% in the National Medical Residency Exam (Turkey)
  • 11/2009- Ranked in top 10% in the National Internal Medicine In-service Exam (USA)
  • 06/2014- Selected as chief fellow for Hematology/Oncology Fellowship at Boston Medical Center matol.
  • 2008 May- 80 (5):381-5.